⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CATX News
Perspective Therapeutics, Inc.
$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors
prnewswire.com
ONCY
RNXT
VSTM
PFE
CATX
Catalyx dévoile une solution de dégagement de ligne activée par l'IA afin de réduire les goulots d'étranglement dans les sciences de la vie USA - Français USA - English USA - English USA - español USA - Deutsch
prnewswire.com
CATX
Catalyx Unveils AI-Powered Line Clearance Solution to Reduce Manufacturing Bottlenecks in Life Sciences USA - English USA - English
prnewswire.com
CATX
Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
CATX
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium
globenewswire.com
CATX
Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
CATX
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium
globenewswire.com
CATX
Informe de Catalyx revela cuellos de botella en la fabricación de la industria de las ciencias de la vida USA - español USA - English USA - Français USA - English USA - Deutsch
prnewswire.com
CATX
Catalyx Report Reveals Persistent Manufacturing Bottlenecks in Life Sciences Industry USA - English USA - English USA - English USA - Deutsch USA - español USA - Français USA - Deutsch USA - English USA - español
prnewswire.com
CATX
Catalyx Report Reveals Persistent Manufacturing Bottlenecks in Life Sciences Industry USA - English USA - English USA - Français USA - Deutsch USA - español
prnewswire.com
CATX